高级检索
当前位置: 首页 > 详情页

Oxymatrine prevents synovial inflammation and migration via blocking NF-κB activation in rheumatoid fibroblast-like synoviocytes.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [a]Collaborative Innovation Center of Miao medicine, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China [b]State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China [c]Department of Hematology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China [d]Department of the first Orthopedics, The 2nd Affiliated Hospital, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China
出处:
ISSN:

关键词: Oxymatrine Fibroblast-like synoviocytes Inflammation Migration NF-κB

摘要:
The fibroblast-like synoviocytes (FLSs) has the aggressive phenotype, which is very important for cartilage destruction in rheumatoid arthritis (RA). To the pathology of RA, the increased FLSs migration, activation and proliferation are essential factors. Oxymatrine is a traditional Chinese herb, which is the extraction from the root of Sophora flavescens and regarded as quinolizidine alkaloid compounds and has been shown to inhibit inflammation, proliferation and migration in vitro or vivo. However, whether oxymatrine effects in the treatment of RA FLSs is undefined. In our study, the inhibition of oxymatrine in RA FLSs inflammation, proliferation and migration in RA FLS are evaluated. We found that oxymatrine decreased the IL-6 and IL-8 expression and the proliferation, migration and invasion of RA FLSs. We also evaluated the molecular mechanisms and we found the effect of oxymatrine on NF-κB activation. The results showed that oxymatrine inhibited the activity of NF-κB. And the treatment activity of oxymatrine on collagen-induced arthritis (CIA) was further explored by us. Thus, we conclude that oxymatrine may protect joint destruction of RA by inhibiting synoviocyte activation, migration, invasion, and proliferation. Copyright © 2017 Elsevier B.V. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 3 区 医学
小类 | 3 区 免疫学 3 区 药学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 药学 3 区 免疫学
JCR分区:
出版当年[2016]版:
Q2 PHARMACOLOGY & PHARMACY Q3 IMMUNOLOGY
最新[2023]版:
Q1 PHARMACOLOGY & PHARMACY Q2 IMMUNOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [a]Collaborative Innovation Center of Miao medicine, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China [*1]Collaborative Innovation Center of Miao Medicine, Guiyang College of Traditional Chinese Medicine, Huaxi University Town, Guiyang, Guizhou 550025, China
共同第一作者:
通讯作者:
通讯机构: [a]Collaborative Innovation Center of Miao medicine, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China [d]Department of the first Orthopedics, The 2nd Affiliated Hospital, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, China [*1]Collaborative Innovation Center of Miao Medicine, Guiyang College of Traditional Chinese Medicine, Huaxi University Town, Guiyang, Guizhou 550025, China [*2]Department of the First Orthopedics, The 2nd Affiliated Hospital, Guiyang College of Traditional Chinese Medicine, Guiyang, Guizhou, Feishan Street, 510000, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2021 今日访问量:0 总访问量:646 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号